CDH11 and rheumatoid arthritis: Being a mediator of EMT in the development of organ fibrosis and a contributor to the inflammatory process in rheumatoid arthritis, it could be hypothesized that CDH11 is a newly identified candidate therapeutic target for fibrosis in IBD.